News About: Pharm. Industry
Bukwang acquires the new international occupational healthy and safety standards as pharma
Bukwang Pharm(CEO Hee-Won Yoo) announced to acquire ‘ISO45001,’ the occupational health and safety standards.
Newly created by the International Organization for Standardization this March, ISO45001 is a new set of s...
“Samsung Biologics might become touchstone for financial reform”
It was argued that Samsung Biologics with accounting fraud and IPO legitimacy issues might become the ‘touchstone for financial reform.’
Won-Gu Ahn, former Director of the Daegu Regional Tax Service, expressed overal...
Yuyu Pharma exceeds 50 million tablets collectively with Yuclid for the past 10 years
Yuyu Pharma(CEO In-Seok Choi) celebrated the 10-year anniversary of ‘Yuclid,’ a self-developed incrementally modified antiplatelet drug.
About 56,966,712 tablets or 661,750 units(30T, 300T) of Yuclid have been sold a...
Huons acquires U.S. patent of ‘nanodrop’
Huons(CEO Ki-Ahn Um) announced on the 25th that the company acquired the U.S. approval of the ‘nanodrops(HU-007)’ being developed with a Korean Phase III clinical trial.
The U.S. patent is the manufacturing method an...
New records with pharmaceutical and bio-pharma ‘technology exchange’ in Jeju
The Korea’s largest pharmaceutical and bio-pharma technology exchange ‘Interbiz Bio-Partnering & Investment Forum 2018’ held at ‘Phoenix Jeju’ between 4 and 6 July will become the largest event ever both in size and c...
Daewoong Pharmaceutical acquires GMP approval from EU for Nabota Factory
Acquiring the cGMP from the U.S. last May and the GMP from the Health Canada, Daewoong Pharmaceutical’s(CEO Seung-Ho Jeon) Nabota Factory acquired the EU GMP from the European Medicines Agency(EMA) on the 18th.
Daewo...
“It is important to make prior agreement when accepting ‘considered working hours’ for medical representatives”
In the pharmaceutical field, it was suggested that it would be able to flexibly assess working hours when employees such as salesmen work outside of the office under the ‘considered working hour system.’
However, a p...
JW Holdings sells its Seocho building for KRW 148 billion
JW Holdings will sell JW Tower in Seocho-dong.
JW Holdings announced on the 20th that the company’s affiliated company ‘KVG 2’ decided to sell its Seocho-dong building to ‘KORAMCO Fund.’
The sales price is KRW 148 b...
Korea Otsuka Pharmaceutical decided as the world’s first ‘Digital Medicine’ manufacturing site
Korea Otsuka Pharmaceutical was selected as the world’s first ‘Digital Medicine’ manufacturing facility.
According to Korea Otsuka Pharmaceutical on the 21st, the Korea Otsuka Pharmaceutical Hyangnam Factory was deci...
Celltrion Healthcare to sell ‘Herzuma’ in 7 European countries
Celltrion Healthcare is expanding the number of countries to sell ‘Herzuma(generic name: trastuzumab),’ an antibody biosimilar for the treatment of breast cancer and stomach cancer.
Celltrion Healthcare launched ‘Her...
